LEVELS OF DOPAMINE AND 3,4-DIHYDROXYPHENYLACETIC ACID IN THE ADENOHYPOPHYSIS OF NORMOTENSIVE AND HYPERTENSIVE RATS

被引:8
作者
SIM, MK
HSU, TP
机构
[1] Department of Pharmacology, Faculty of Medicine, National University of Singapore
关键词
3-methoxy-4-hydroxyphenylacetic acid; Adenohypophysis; Dopac; Dopamine; Spontaneously hypertensive rats;
D O I
10.3109/10641969009074738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The levels of dopamine and its metabolites in the adenohypophysis of the normo- and hypertensive rats were determined. Dopamine was present as the free and sulfate-conjugated form in the adenohypophysis of the spontaneously hypertensive rat (SHR), Wistar Kyoto (WKY) and Sprague-Dawley (SD) rats. The levels of both the free and conjugated dopamine in the adenohypophysis of the SHR were 5.49 ± 2.91 (mean ± SEM) and 4.27 ± 3.31 pmoles/ mg protein respectively. These values were not significantly different from those of the WKY and SD. 3,4-Dihydroxyphenylacetic acid (dopac), present as the free and sulfate-conjugated form, was found to be the only metabolite of dopamine in the adenohypophysis of the three animals. The levels of both free and conjugated dopac in the adenohypophysis of the SHR were 7.0 ± 2.5 and 75.5 ± 33.5 pmoles/mg protein respectively and these values were signficantly different from those of the WKY (1.12 ± 0.47 and 4.17 ± 0.48 pmoles/mg protein) and SD (1.87 ± 0.62 and 3.5 ± 1.11 pmoles/mg). The results indicate that (a) there is no deficiency of free dopamine in the adenohypophysis of the SHR and hypertension in these animals is unlikely to be related to the catecholamine level in the endocrine gland, (b) the dopamine turnover in either the tuberoinfundibular tract or the adenohypophysis of the SHR is greatly enhanced. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:343 / 353
页数:11
相关论文
共 11 条
[1]   DOPAMINE IN HYPOPHYSEAL PORTAL PLASMA OF RAT DURING ESTROUS-CYCLE AND THROUGHOUT PREGNANCY [J].
BENJONATHAN, N ;
OLIVER, C ;
WEINER, HJ ;
MICAL, RS ;
PORTER, JC .
ENDOCRINOLOGY, 1977, 100 (02) :452-458
[2]  
FOLDES A, 1973, BIOCHIM BIOPHYS ACTA, V327, P356
[3]  
KAROUM F, 1977, J PHARMACOL EXP THER, V201, P654
[4]  
LEFF CSE, 1984, DOPAMINE RECEPTOR AG, P23
[5]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[7]  
MOK JSL, IN PRESS HYPERTENSIO
[9]  
TOUMISTO J, 1985, PHARMACOL REV, V37, P249
[10]   CATECHOLAMINE GLUCURONIDATION - AN IMPORTANT METABOLIC PATHWAY FOR DOPAMINE IN THE RAT [J].
WANG, PC ;
KUCHEL, O ;
BUU, NT ;
GENEST, J .
JOURNAL OF NEUROCHEMISTRY, 1983, 40 (05) :1435-1440